Company Profile

■ Company Name

Nobelpharma Co., Ltd.

■ Date of Establishment

6 June 2003

■ Capital

161,650,000 Yen

■ Shareholders

Hisanaga & Co., Y.K.
Inabata & Co., Ltd.
Development Bank of Japan Inc.

■ Address

Kyodo Bldg. (Horidome)
12-10 Nihonbashi-kobunacho, Chuo-Ku, Tokyo

■ Contact Details

TEL: +81-3-5651-1160
FAX: +81-3-5651-1222
e-mail: info@nobelpharma.co.jp

■ President & CEO

Jin Shiomura

■ Directors

Eiji Suzuki, Director
Toru Tanimura, Director,
(Group Manager, Business Management Group, Financial Management Dept., Inabata & Co.,Ltd)
Yasuyuki Fujimoto, Director,
（Group Manager, Lifescience Group, Chemicals Div., Inabata & Co.,Ltd)
Nobukazu Kuboi, Auditor
(Group Manager, Accounting Group, Financial Management Dept., Inabata & Co.,Ltd)
Shigeki Shimasaki, Executie Officer, COO, General Manager, Research & Development Div.
Toshihiko Asano, Executie Officer, General Manager, Marketing & Sales Div.

■ Counselor

Toshihide Endo (ex-COO, General Manager, Research & Development Div.)

■ Advisors

Osamu Naito
(ex-Chief Executiｖe Officer of Iatron)
Shinichiro Handa
(ex-Chief Executiｖe Officer of Mitsubishi Pharma Corp.)
Kentaro Fujimoto, Ph.D.
(ex-head of the Reserach institute of Asahi Kasei Corp.)
Takefumi Matsuo, M.D., Ph.D.
(Honorable Head Director of Hyogo Prefectural Awaji Hospital, Chair of Hyogo Pref. Medical Association)

■ Number of Employees

93

■ Business Connection

（Distributors）
Nippon Shinyaku Co., Ltd.
Fuji Pharma Co., Ltd.
Alfresa Pharma Corporation
(Manufacturers）
Fuji Pharma Co., Ltd.
Choseido Pharmaceutical Co.,Ltd.
Toyobo Co.,Ltd.
（Licensers）
Janssen Pharmaceutical K.K.
Teva Pharmaceuticals　USA, Inc.
Pfizer Inc.
Eisai, Inc.

■ Bank

Bank of Tokyo-Mitsubishi UFJ
Mizuho Bank Ltd.
Japan Finance Corporation
Resona Bank, Limited
The Shoko Chukin Bank Limited
The Tokyo Shinkin Bank